Home
Regulatory & Reimbursement Considerations for IVDMIA’s in the United States
2 June 2009
Regulatory & Reimbursement Considerations for IVDMIA’s in the United States

In Association with:

In Vitro Diagnostic Multi-variate Index Assays (IVDMIAs) are a new class of diagnostic test.  It is predicted they will alter the healthcare system and dramatically change the way the FDA regulates devices.  In the two years since Agendia succeeded in getting the first IVDMIA approved by the FDA much confusion has arisen surrounding the FDA’s guidelines for these devices.  This workshop, hosted by one of the regulators instrumental in Agendia’s success, aims to help dispel some of this confusion and make it possible for other regulators to succeed in getting approval for their devices.

Key Objectives:

• GAIN a better understanding of the regulatory environment surrounding IVDMIAs
• LEARN from the regulator involved in the first IVDMIA FDA approval
• UNDERSTAND the common pitfalls and how to overcome them

About the Workshop Leader:

Guido Brink serves as the Director of Quality Management, Regulatory Affairs for the Amsterdam and Huntington Beach-based diagnostics company, Agendia, a world leader in gene expression analysis-based diagnostics.  One of the five pioneers when the company was founded, Brink is also responsible for Agendia’s reimbursement activities worldwide.

In 2007, under Brink’s guidance, Agendia obtained the first U.S. Food and Drug Administration (FDA) clearance ever issued for an in vitro diagnostic multivariate index assay (IVDMIA) for the company’s 70-gene breast cancer prognostic test, MammaPrint™.  Based on his successful implementation of quality systems, Mr. Brink was asked to assist the Agency in the development of the Special Control Guidance Document (SCGD) for breast cancer testing in the U.S.  

Also under Brink’s supervision, Agendia became the first microarray laboratory in the world to acquire an ISO 17025 accreditation – a global standard used by testing and calibration laboratories. He also oversaw the accreditation of Agendia’s laboratory from the U.S. College of American Pathologists (CAP) and the U.S. Government under the Clinical Laboratory Improvement Amendment (CLIA).

In addition to overseeing quality control, regulatory affairs and global reimbursement for Agendia, Brink managed the company’s information and communication systems.  He is responsible for the development of MammaPrint’s sampling, preservation and transport system for tissue at room temperature, as well as the implementation of the automated ordering and reporting systems available through the company’s website.

About the Organisation:

Agendia is committed to improving the quality of life of people suffering from cancer through enabling effective personalized medicine. The company is pioneering the development and commercialization of validated tests that assist healthcare professionals and pharmaceutical companies to determine the diagnosis, prognosis and therapeutic responsiveness of cancers in individual patients.

In 2004, Agendia became the first company to commercialize a prognostic test that predicts the risk of breast cancer recurrence (MammaPrint). In 2007, MammaPrint became the first in vitro Diagnostic Multivariate Index Assay (IVDMIA) to acquire clearance from the US Food and Drug Administration (FDA). Agendia recently presented its new colon cancer prognosis profile, ColoPrint, which is currently undergoing further validation in the anticipation of developing a test to predict the likelihood of the cancer spreading at an early stage in the disease.

Workshop agenda

clock

13:30

Registration & Coffee

clock

14:00

Welcome and Introductions

clock

14:10

REGULATORY BASICS FOR MEDICAL DEVICE REGULATION

  • Current US guidelines
  • clock

    14:20

    HISTORY AND FUTURE OF IVDMIA REGULATION BY FDA

  • Guidance documents from FDA
  • Definition of IVDMIA
  • Where next with IVDMIA  regulation?
  • clock

    14:50

    PITFALLS FOR SUCCESSFUL IVDMIA CLEARANCE

  • Common difficulties in obtaining clearance
  • Methods for overcoming these issues
  • clock

    15:20

    Afternoon Tea

    clock

    15:40

    CASE STUDY: MAMMAPRINT

  • A look at the first FDA approved IVDMIA
  • Development & clearance process
  • Methods adopted by Agendia for success
  • clock

    16:10

    REIMBURSEMENT OF IVDMIA IN US

  • Current reimbursement stance in US
  • Affect of this on test
  • clock

    16:40

    DISCUSSION

  • Opportunity to discuss the topics of the workshop
  • clock

    17:00

    Close of Executive Briefing

    Crowne Plaza Hotel - St James

    Buckingham Gate 45/51
    London SW1E 6AF
    United Kingdom

    Crowne Plaza Hotel - St James

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.